[Clinico-therapeutic evaluation of a new inhibitor of monoamine oxidase, nialamide].
D000889:Anti-Arrhythmia Agents; D004791:Enzyme Inhibitors; D006331:Heart Diseases / Q000628:therapy*; D006801:Humans; D008995:Monoamine Oxidase; D009525:Niacin / Q000031:analogs & derivatives; D009526:Nialamide; D009539:Nicotinic Acids; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*
D000889:Anti-Arrhythmia Agents; D004791:Enzyme Inhibitors; D009539:Nicotinic Acids; D009525:Niacin; D010088:Oxidoreductases; D008995:Monoamine Oxidase; D009526:Nialamide
HEART DISEASES/therapy; NICOTINIC ACID/related compounds; OXIDASES/antagonists